| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 08/15/2001 | CN1307893A Capsule and its production process |
| 08/15/2001 | CN1307885A Vesania-treating medicine |
| 08/15/2001 | CN1307883A Chinese medicine for treating lymph tuberculosis |
| 08/15/2001 | CN1307882A Hemopathy treating medicine |
| 08/15/2001 | CN1307881A Medicine for treating cough and asthma |
| 08/15/2001 | CN1307879A Chinese medicine for treating male veneral disease |
| 08/15/2001 | CN1307878A Zhidaipian tablet for treating foolishness and its preparation |
| 08/15/2001 | CN1307876A Xinmaikang medicine |
| 08/15/2001 | CN1307874A Diabetes treating medicine and its preparation |
| 08/15/2001 | CN1307872A Selenium product of natural marine organism and its preparation |
| 08/15/2001 | CN1307871A Goat fetus essence injecta and its preparation process |
| 08/15/2001 | CN1069541C Medicine for treatment of cancer |
| 08/15/2001 | CN1069538C Typhlosis-resistant liquid for ophthalmopathy as complication of diabetes |
| 08/15/2001 | CN1069533C Medicine for preventing cerebral thrombus |
| 08/15/2001 | CN1069532C Medicine for preventing hypertension cere hemorrhage |
| 08/15/2001 | CN1069530C Instant powder for mourishing blood and its prepn. method |
| 08/15/2001 | CN1069526C Medicine for curing hyperosteogeny |
| 08/15/2001 | CN1069525C Turtle oil, soft-shelled turtle oil compositions and the preparation thereof |
| 08/15/2001 | CN1069524C Donkey-hide gelatin calcium oral liquor and its producing process |
| 08/14/2001 | US6274702 Bone stimulating factor |
| 08/14/2001 | US6274378 Methods and compositions for obtaining mature dendritic cells |
| 08/14/2001 | US6274322 Transfection kit; for use as nucleotide sequence tool during genetic engineering |
| 08/14/2001 | US6274148 Hepatitis C virus asialoglycoproteins |
| 08/14/2001 | US6274090 Apparatus and method of preparation of stable, long term thrombin from plasma and thrombin formed thereby |
| 08/14/2001 | CA2243570C Mixture of recombinant vaccinia vectors as polyenv vaccines for hiv |
| 08/09/2001 | WO2001057534A2 Compositions and methods for reducing autoimmunity |
| 08/09/2001 | WO2001057234A2 Biopolymer thickener |
| 08/09/2001 | WO2001057222A1 A protease, a gene therefor and the use thereof |
| 08/09/2001 | WO2001057208A2 Mlp gene, nucleic acids, polypeptides and the utilization thereof |
| 08/09/2001 | WO2001057191A1 Generation of dopaminergic neurons from human nervous system stem cells |
| 08/09/2001 | WO2001057074A1 Ligands for fpr class receptors that induce a host immune response to a pathogen or inhibit hiv infection |
| 08/09/2001 | WO2001057069A2 Targeting peptides |
| 08/09/2001 | WO2001057060A1 Bcl-2-like polynucleotides, polypeptides, and antibodies |
| 08/09/2001 | WO2001056608A1 Human herpesvirus 6a and 6b transfer factors for the treatment of chronic fatigue syndrome and multiple sclerosis |
| 08/09/2001 | WO2001056599A2 Hyperthermia and immunotherapy for leukemias, lymphomas, and solid tumors |
| 08/09/2001 | WO2001056598A2 Methods for preventing or attenuating pathoangiogenic conditions by using gbs-toxin (cm101) |
| 08/09/2001 | WO2001056596A1 Use of lysosomal acid lipase for treating atherosclerosis and related diseases |
| 08/09/2001 | WO2001056405A2 A method for maintaining or improving the synthesis of mucins |
| 08/09/2001 | WO2001056379A1 A method of quieting a corneal inflammatory response |
| 08/09/2001 | WO2001021767A3 Pluripotent embryonic-like stem cells, compositions, methods and uses thereof |
| 08/09/2001 | WO2001019966A3 Isolation of muscle-derived stem cells and uses therefor |
| 08/09/2001 | WO2001019374A3 Glucosamine and egg reducing inflammation |
| 08/09/2001 | WO2001008694A3 Direct arterial infiltration for production of vascular pathology |
| 08/09/2001 | WO2001007568A3 Muscle cells and their use in cardiac repair |
| 08/09/2001 | WO2001006988A3 Super-active porcine growth hormone releasing hormone analog |
| 08/09/2001 | WO2001006949B1 In vitro repair of bone and/or cartilage defects |
| 08/09/2001 | WO2001005940A3 Methods for producing and preparing cells for cell therapy |
| 08/09/2001 | WO2001004318A3 Myxoma virus genes for immune modulation |
| 08/09/2001 | WO2001000241A3 Novel vector complexes and their use in gene therapy |
| 08/09/2001 | WO2000074729A3 Alpha or beta emitters to fragments in radioimmunotherapy |
| 08/09/2001 | WO2000069257A3 Genetic modification of male germ cells for generation of transgenic species and genetic therapies |
| 08/09/2001 | WO2000066716A3 Method for producing organisms exhibiting increased sterol glycoside production and use of the sterol glycosides |
| 08/09/2001 | WO2000037643A3 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 08/09/2001 | US20010012965 In vitro production of transplantable cartilage tissue |
| 08/09/2001 | US20010012840 Topical transdermal treatments |
| 08/09/2001 | US20010012834 Treating pulmonary disorders with gaseous agent causing repletion of GSNO |
| 08/09/2001 | US20010012833 Method for treating neuromuscular disorders and conditions with botulinum toxin types A and B |
| 08/09/2001 | US20010012629 Given grampositive bacteria strains with reduced 7alpha-dehydroxylase activity and reduced rate of bile acid deconjugation; treating biliary dyspepsia, cholelithiasis, hepatopathies, inflammation of the colon |
| 08/09/2001 | US20010012626 Polynucleotides encoding Presenilin 1 (PS1); diagnosing a patient having an increased likelihood of contracting Alzheimer's disease |
| 08/09/2001 | US20010012610 Of biological specimens by true vitrification comprising dehydrating a biologically active material at a temperature higher than the suggested storage temperatures followed by cooling of the sample to the storage temperature |
| 08/09/2001 | US20010012513 Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
| 08/09/2001 | DE10003653A1 Vektorkonstrukte zur gentherapeutisch vermittelten Radioiodtherapie entdifferenzierter und medullärer Schilddrüsen-Karzinome sowie nicht-thyreoidaler Tumore und ihrer Metastasen Vector constructs for gene therapy mediated radioiodine therapy of medullary thyroid carcinoma and dedifferentiated and non-thyroidal tumors and their metastases |
| 08/09/2001 | CA2399063A1 A method for maintaining or improving the synthesis of mucins |
| 08/09/2001 | CA2399058A1 Targeting peptides |
| 08/09/2001 | CA2399032A1 Ligands for fpr class receptors that induce a host immune response to a pathogen or inhibit hiv infection |
| 08/09/2001 | CA2398995A1 Lipid hydrolysis therapy for atherosclerosis and related diseases |
| 08/09/2001 | CA2398957A1 Human herpesvirus 6a and 6b transfer factors for the treatment of chronic fatigue syndrome and multiple sclerosis |
| 08/09/2001 | CA2398915A1 Hyperthermia and immunotherapy for leukemias, lymphomas, and solid tumors |
| 08/09/2001 | CA2398255A1 Bcl-2-like polynucleotides, polypeptides, and antibodies |
| 08/09/2001 | CA2369050A1 Methods for preventing or attenuating pathoangiogenic conditions |
| 08/08/2001 | EP1121948A1 Device and method for perfusing peritoneal dialyzing fluid |
| 08/08/2001 | EP1121930A1 Drug preparation "histochrome" for treating acute myocardial infarction and ischaemic heart diseases |
| 08/08/2001 | EP1121929A1 Drug preparation "histochrome" for treating ocular conditions |
| 08/08/2001 | EP1121442A2 Recombinant e1a deleted adenoviral vectors |
| 08/08/2001 | EP1121441A2 Selectively replicating viral vectors |
| 08/08/2001 | EP1121429A2 Gene therapy of alzheimer's disease by delivery of an encoded apolipoprotein e |
| 08/08/2001 | EP1121374A1 Bone morphogenic protein-induced genes and polypeptides, and their use in diagnostic and therapeutic methods |
| 08/08/2001 | EP1121165A1 Method for production of stroma-free hemoglobin |
| 08/08/2001 | EP1121138A2 Compositions for the treatment of atherosclerosis and related conditions |
| 08/08/2001 | EP1121137A1 Method for killing tumor and tumor associated endothelial cells using adenoviral mutants |
| 08/08/2001 | EP1121136A2 Methods of administering adenoviral vectors |
| 08/08/2001 | EP1121064A1 Method and device for preparing a dental implant by immersion in a mesenchymal cell culture |
| 08/08/2001 | EP0837878B1 Antitumor proteins from rana pipiens oocytes |
| 08/08/2001 | EP0707486B1 Cutaneous rejuvenating and healing product, method for its manufacture and uses thereof |
| 08/08/2001 | EP0669829B1 Enhancement of xenograft tolerance and porcine cytokines therefor |
| 08/08/2001 | EP0641223B1 Biotherapeutic cell-coated microspheres |
| 08/08/2001 | CN1307632A Ependymal neural stem cells and method for their isolation |
| 08/08/2001 | CN1307487A Method of treating endotoxemia |
| 08/08/2001 | CN1307478A Food composition and method of using same |
| 08/08/2001 | CN1306857A Medicine for strengthening physique and strengthening immunity |
| 08/08/2001 | CN1306849A Chinese medicine composition for sterility |
| 08/08/2001 | CN1306847A Ointment for treating prostatitis and its usage |
| 08/08/2001 | CN1306845A External-use medicine for treating psoriasis |
| 08/08/2001 | CN1306840A Chinese medicine for treating acute and chronic rhinitis and nasosinusitis |
| 08/08/2001 | CN1306835A External-use medicine for treating facial palsy and its preparation |
| 08/08/2001 | CN1306832A Analgesic composition |
| 08/08/2001 | CN1306826A Amino acid health oral liquid for middle-aged and old people |
| 08/08/2001 | CN1306824A Water soluble medical chitose preparation and its preparation |
| 08/08/2001 | CN1069217C Immune serum globulin for intravenous injection and preparing method thereof |
| 08/08/2001 | CN1069211C Gastrosis plaster |